Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993, USA.
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, John Hopkins University, Baltimore, MD 21218, USA.
Exp Biol Med (Maywood). 2021 Apr;246(7):861-875. doi: 10.1177/1535370220985808. Epub 2021 Jan 19.
The last decade has seen many exciting technological breakthroughs that greatly expanded the toolboxes for biological and biomedical research, yet few have had more impact than induced pluripotent stem cells and modern-day genome editing. These technologies are providing unprecedented opportunities to improve physiological relevance of experimental models, further our understanding of developmental processes, and develop novel therapies. One of the research areas that benefit greatly from these technological advances is the three-dimensional human organoid culture systems that resemble human tissues morphologically and physiologically. Here we summarize the development of human pluripotent stem cells and their differentiation through organoid formation. We further discuss how genetic modifications, genome editing in particular, were applied to answer basic biological and biomedical questions using organoid cultures of both somatic and pluripotent stem cell origins. Finally, we discuss the potential challenges of applying human pluripotent stem cell and organoid technologies for safety and efficiency evaluation of emerging genome editing tools.
过去十年见证了许多激动人心的技术突破,极大地扩展了生物学和生物医学研究的工具包,但很少有技术比诱导多能干细胞和现代基因组编辑产生更大的影响。这些技术为提高实验模型的生理相关性、深化我们对发育过程的理解以及开发新疗法提供了前所未有的机会。受益于这些技术进步的研究领域之一是三维人类类器官培养系统,它在形态和生理上类似于人类组织。在这里,我们总结了人类多能干细胞的发展及其通过类器官形成的分化。我们进一步讨论了如何应用遗传修饰,特别是基因组编辑,使用源自体细胞和多能干细胞的类器官培养物来回答基本的生物学和生物医学问题。最后,我们讨论了应用人类多能干细胞和类器官技术评估新兴基因组编辑工具的安全性和效率所面临的潜在挑战。